🎉 M&A multiples are live!
Check it out!

Coloplast Valuation Multiples

Discover revenue and EBITDA valuation multiples for Coloplast and other public comps.

See Coloplast Valuation Multiples

Coloplast Overview

About Coloplast

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.


Founded

1954

HQ

Denmark
Employees

16.2K+

Website

coloplast.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$28.1B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Coloplast Financials

Coloplast has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Coloplast achieved revenue of $3.8B and an EBITDA of $1.2B.

Coloplast expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Coloplast valuation multiples based on analyst estimates

Coloplast P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $3.2B $3.4B $3.8B n/a XXX
Gross Profit $2.2B $2.3B $2.6B XXX XXX
Gross Margin 69% 67% 68% XXX XXX
EBITDA $1.0B $1.1B $1.2B n/a XXX
EBITDA Margin 32% 32% 31% NaN% XXX
Net Profit $657M $668M $706M XXX XXX
Net Margin 21% 20% 19% XXX XXX
Net Debt $2.5B $2.5B $2.9B XXX XXX

Financial data powered by Morningstar, Inc.

Coloplast Stock Performance

As of February 10, 2025, Coloplast's stock price is DKK 786 (or $110).

Coloplast has current market cap of DKK 177B (or $24.8B), and EV of DKK 201B (or $28.1B).

See Coloplast trading valuation data

Coloplast Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$28.1B $24.8B XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Coloplast Valuation Multiples

As of February 10, 2025, Coloplast has market cap of $24.8B and EV of $28.1B.

Coloplast's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Coloplast's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Coloplast and 10K+ public comps

Coloplast Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $28.1B XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E n/a XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Coloplast Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Coloplast Valuation Multiples

Coloplast's NTM/LTM revenue growth is n/a

Coloplast's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Coloplast's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Coloplast's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Coloplast and other 10K+ public comps

Coloplast Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 10% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 10% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 33% XXX XXX XXX XXX
G&A Expenses to Revenue 5% XXX XXX XXX XXX
R&D Expenses to Revenue 3% XXX XXX XXX XXX
Opex to Revenue 41% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Coloplast Public Comps

See valuation multiples for Coloplast public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
Electromed XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Coloplast M&A and Investment Activity

Coloplast acquired  XXX companies to date.

Last acquisition by Coloplast was  XXXXXXXX, XXXXX XXXXX XXXXXX . Coloplast acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Coloplast

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Coloplast

When was Coloplast founded? Coloplast was founded in 1954.
Where is Coloplast headquartered? Coloplast is headquartered in Denmark.
How many employees does Coloplast have? As of today, Coloplast has 16.2K+ employees.
Who is the CEO of Coloplast? Coloplast's CEO is Mr. Kristian Villumsen.
Is Coloplast publicy listed? Yes, Coloplast is a public company listed on CSE.
What is the stock symbol of Coloplast? Coloplast trades under COLO B ticker.
When did Coloplast go public? Coloplast went public in 1993.
Who are competitors of Coloplast? Similar companies to Coloplast include e.g. Philips, Perspective Therapeutics, Electromed, InfuSystem.
What is the current market cap of Coloplast? Coloplast's current market cap is $24.8B
What is the current revenue growth of Coloplast? Coloplast revenue growth between 2023 and 2024 was 10%.
Is Coloplast profitable? Yes, Coloplast is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.